RxDoctor Payments DataLook up a doctor →

Robert Riesenberg

Psychiatry · Atlanta, GANPI 1417116906

Payments from drug & device makers

$51,122,485in general payments, 2019–2025

Across 3,386 payments — averaging $15,098 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$12M
  • AbbVie$10.8M
  • Teva Pharmaceuticals USA, Inc.$4.4M
  • Sunovion Pharmaceuticals Inc.$4.1M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3.5M
  • Sumitomo Pharma America, Inc.$2.5M
  • plus $13.8M from 36 others
$5,857in research payments, 2019–2025

Across 7 payments — averaging $836.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$3K
  • Eli Lilly$1K
  • AbbVie$1K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$48

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$51,122,485 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Other psychiatry in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →